BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1384016)

  • 1. Mesothelial and related neoplasms in children and adolescents: a clinicopathologic and immunohistochemical analysis of eight cases.
    Coffin CM; Dehner LP
    Pediatr Pathol; 1992; 12(3):333-47. PubMed ID: 1384016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas.
    Khoury N; Raju U; Crissman JD; Zarbo RJ; Greenawald KA
    Hum Pathol; 1990 Aug; 21(8):811-9. PubMed ID: 1696923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
    Goldblum J; Hart WR
    Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peritoneal mesothelioma in childhood with long-term survival.
    Geary WA; Mills SE; Frierson HF; Pope TL
    Am J Clin Pathol; 1991 Apr; 95(4):493-8. PubMed ID: 1707588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse malignant peritoneal mesothelioma in a young woman with a high serum level of CA125.
    Duan HJ; Itoh N; Yamagami O; Katsuyama T; Shigematsu H
    Acta Pathol Jpn; 1991 Feb; 41(2):158-63. PubMed ID: 1710413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of diffuse malignant mesothelioma].
    Stosiek P; Goertchen R
    Zentralbl Allg Pathol; 1986; 132(2):119-28. PubMed ID: 2431554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized fibrous tumors of the pleura: correlation of histopathological, immunohistochemical and ultrastructural features.
    Steinetz C; Clarke R; Jacobs GH; Abdul-Karim FW; Petrelli M; Tomashefski JF
    Pathol Res Pract; 1990 Jun; 186(3):344-57. PubMed ID: 1696007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison.
    Bollinger DJ; Wick MR; Dehner LP; Mills SE; Swanson PE; Clarke RE
    Am J Surg Pathol; 1989 Aug; 13(8):659-70. PubMed ID: 2473660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized malignant mesothelioma.
    Allen TC; Cagle PT; Churg AM; Colby TV; Gibbs AR; Hammar SP; Corson JM; Grimes MM; Ordonez NG; Roggli V; Travis WD; Wick MR
    Am J Surg Pathol; 2005 Jul; 29(7):866-73. PubMed ID: 15958850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.
    Wirth PR; Legier J; Wright GL
    Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
    Epstein JI; Budin RE
    Hum Pathol; 1986 May; 17(5):514-9. PubMed ID: 2422109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
    Cagle PT; Truong LD; Roggli VL; Greenberg SD
    Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomesotheliomatous carcinoma involving pleura and peritoneum: A clinicopathologic and immunohistochemical study of three cases.
    Shah IA; Salvatore JR; Kummet T; Gani OS; Wheeler LA
    Ann Diagn Pathol; 1999 Jun; 3(3):148-59. PubMed ID: 10359850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pleural mesothelioma producing human chorionic gonadotropin. Report of two cases.
    Okamoto H; Matsuno Y; Noguchi M; Morinaga S; Fujioka Y; Tsuchiya R; Tamura T; Shimosato Y
    Am J Surg Pathol; 1992 Oct; 16(10):969-74. PubMed ID: 1384371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.
    Beer TW; Buchanan R; Matthews AW; Stradling R; Pullinger N; Pethybridge RJ
    Hum Pathol; 1998 Mar; 29(3):246-51. PubMed ID: 9496827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.